(Q39820104)

14 September 2017

Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. (English)

1 reference

14 September 2017

1 reference

1 reference

cryptococcal meningitis

1 reference

Perfect JR

1

1 reference

14 September 2017

Wright KA

series ordinal

2

1 reference

14 September 2017

Hobbs MM

series ordinal

3

1 reference

14 September 2017

Durack DT

series ordinal

4

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

33

1 reference

14 September 2017

10

1 reference

14 September 2017

1735-1740

1 reference

Chronic cryptococcal meningitis: a new experimental model in rabbits

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Treatment of paracoccidioidomycosis with ketoconazole: A three-year experience

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Oral fluconazole therapy for patients with acquired immunodeficiency syndrome and cryptococcosis: experience with 22 patients.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Oral ketoconazole. An effective and safe treatment for dermatophytosis

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172747

Obfuscation of the Activity of Antifungal Antimicrobics by Culture Media

20 August 2018

1 reference

12 December 2020

Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study

1 reference

12 December 2020

Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis

1 reference

12 December 2020

Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits

1 reference

12 December 2020

Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.33.10.1735

1 reference

14 September 2017

1 reference

14 September 2017

1 reference